Elypta AB is a private biotech company headquartered in Solna, Sweden, operating on the Karolinska Institute campus. The firm focuses on developing cancer detection tests based on metabolism and liquid biopsy biomarkers.
Subscribe to see Elypta’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Elypta is a diagnostics company headquartered in Sweden. It has raised at least $27.8M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $21M in June 2022. Xcout tracks 12 named people at Elypta, including Karl Bergman (CEO).
6 more named people on record for Elypta, with roles, board committees and tenure — see the full roster →
At least $27.8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $21M | 9 named | |
| — | $6.8M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.